http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8606277-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ec0024795f45a646ef64b3664ab8a26d |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-195 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195 |
| filingDate | 1986-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96d81d5608f76839ce054faf31395ca6 |
| publicationDate | 1986-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-8606277-A1 |
| titleOfInvention | Utilization of l-ornithine for producing agents to selectively inhibit t-cell-started immunoreactions |
| abstract | L-ornithine is used to produce agents which are intended to selectively inhibit T-cell-started immunoreactions, particularly to selectively inhibit the activation of cytotoxic T-lymphocyte activating cells. |
| priorityDate | 1985-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 29.